Conservative management of uterine adenosarcoma: lessons learned from 20 years of follow-up.
Adenosarcoma of the uterus
Fertility preservation
Gynaecology
Hysteroscopy
Oncology
Surgery
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
29
05
2019
accepted:
14
09
2019
pubmed:
5
10
2019
medline:
16
5
2020
entrez:
5
10
2019
Statut:
ppublish
Résumé
Uterine adenosarcomas (UAs) account for 5-8% of cases of uterine sarcomas. Treatment includes total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO). Fertility preservation is an emerging concept in gynaecology oncology and is particularly relevant in UA, where cases are diagnosed as young as 15-year-old. This manuscript demonstrates a case of UA which was treated conservatively, achieved successful livebirths and underwent completion hysterectomy after two decades of follow-up. This was a retrospective case note review. An 18-year-old nulliparous woman presented with abnormal vaginal bleeding. Ultrasound identified an endometrial polyp, which was histologically diagnosed as low-grade adenosarcoma. She was advised to undergo TAH and BSO, but instead decided to preserve her fertility and opted for conservative management. She was monitored with pelvic ultrasound, hysteroscopy and endometrial biopsy bi-annually, with annual pelvic magnetic resonance imaging for 10 years which was uneventful. 11 years post-operatively she conceived following in-vitro fertilization (IVF) but suffered a miscarriage at 16 weeks likely due to cervical incompetence. She subsequently conceived with twins. She delivered spontaneously preterm at 28 weeks. Both children are alive and well. After 20 years of follow-up, she underwent a laparoscopic hysterectomy with no evidence of recurrence. She remains disease free. Whilst radical completion surgery should be advised in UA, this case, in addition to all published conservatively managed cases of UA, demonstrates that conservative management is possible in appropriately selected women. Intensive monitoring post-operatively is essential owing to the risk of recurrence; however, this may pose deleterious side effects which require consideration.
Identifiants
pubmed: 31584132
doi: 10.1007/s00404-019-05306-6
pii: 10.1007/s00404-019-05306-6
pmc: PMC6814630
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1383-1389Références
Gynecol Oncol. 2010 Nov;119(2):305-8
pubmed: 20688363
Histopathology. 2009 Feb;54(3):355-64
pubmed: 19236512
Gynecol Oncol. 2013 Dec;131(3):634-9
pubmed: 24135678
Acta Obstet Gynecol Scand. 2006;85(6):700-5
pubmed: 16752262
Int J Gynaecol Obstet. 2009 Mar;104(3):177-8
pubmed: 19135669
Gynecol Oncol Rep. 2018 May 09;25:27-29
pubmed: 29977987
Hum Reprod. 2016 Jan;31(1):34-45
pubmed: 26534897
Nat Rev Endocrinol. 2013 Dec;9(12):735-49
pubmed: 24166000
Best Pract Res Clin Obstet Gynaecol. 2013 Jun;27(3):415-20
pubmed: 23482071
Hum Pathol. 1990 Apr;21(4):363-81
pubmed: 2156771
PLoS One. 2013;8(2):e56583
pubmed: 23437176
Int J Gynecol Pathol. 1992;11(2):75-88
pubmed: 1316323
Gynecol Oncol. 2014 Dec;135(3):455-61
pubmed: 25449308
Fetal Diagn Ther. 2004 Jul-Aug;19(4):361-5
pubmed: 15192297
Cancer. 1974 Oct;34(4):1138-49
pubmed: 4371193
World J Surg Oncol. 2017 Apr 19;15(1):87
pubmed: 28424089
Eur J Obstet Gynecol Reprod Biol. 2002 May 10;102(2):111-9
pubmed: 11950476
Acta Obstet Gynecol Scand. 2012 Feb;91(2):204-10
pubmed: 22085381
Gynecol Oncol. 2013 Apr;129(1):140-4
pubmed: 23283300
Gynecol Oncol. 2001 Oct;83(1):89-94
pubmed: 11585418
Geburtshilfe Frauenheilkd. 2015 Oct;75(10):1028-1042
pubmed: 26640293
Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S78-82
pubmed: 25341585
Gynecol Oncol. 2005 May;97(2):624-37
pubmed: 15863170
J Womens Health (Larchmt). 2015 Nov;24(11):899-906
pubmed: 26208166
Gynecol Oncol. 2010 Jan;116(1):131-9
pubmed: 19853898
J Gynecol Oncol. 2017 Jul;28(4):e46
pubmed: 28541635